Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related Bcc Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview
Introduction
U.S. Preventive Services Task force Recommendations
Biology of Prostate Cancer
Prostate Gland
Prostate Gland Function
Growth of the Prostate Gland
Types of Prostate Cancer
Precancerous Conditions of the Prostate
Prostatic Intraepithelial Neoplasia
Proliferative Inflammatory Atrophy
Prostate Cancer Development and Aging
Mechanisms of Disease Development Pathophysiology
Family History
Environmental Factors
Epidemiology and Risk Factors
Hormones
Growth Factors
Genetics
Molecular Mechanisms of Prostate Cancer
the androgen Receptors
Pten
P53
Gstp Genes
Prostate-Specific Antigen
Caveolin-1
Emsy
Amacr
Klf6
Nbs1
Chek2
Mismatch Repair Genes
Hoxb13 Protein Coding Gene
Brca1 and Brca2
Hereditary Prostate Cancer
Prostate Cancer Prevention and Treatment
Conclusion

Chapter 4 Prostate Cancer Information
Detection and Diagnosis
Diagnosis
How Is Prostate Cancer Diagnosed?
Tests To Diagnose Prostate Cancer
Screening, Diagnosis and Management of Prostate Cancer
Recommendations for Prostate Cancer Early Detection
Guidelines for Prostate Cancer Screening
Prostate Cancer Screening Guidelines: Historical Perspective
Recommendations for Early Cancer Detection
Prostate Cancer Screening
Psa
Psa for Early Detection of Prostate Cancer
Psa Testing: Good Or Bad?
Psa Testing Performance
Psa Reference Ranges
Psa Testing and Concerns
Improvements for the Psa Test
Psa Levels and Velocity
Post-Treatment Management of Prostate Cancer and the Psa Test
Pretreatment Staging of Prostate Cancer and Psa Testing
Potential Benefits of Screening
Potential Harm of Screening
Economic Consequence of Psa Testing
Staging and Grading of Prostate Cancer
Diagnostic Biopsy
Prostate Biopsy
Test for Metastasis
New Methods In Development
Microrna Patterns
Non-Mutation Gene Alterations
Gene Fusions
Pca3
Differential Detection of Metabolites
Proteo-Imaging
Protein Patterns In the Blood
Imaging Strategies for Diagnosis of Prostate Cancer
Prostate Cancer Prognosis and Outcomes Predictions
Conclusion

Chapter 5 Prostate Cancer Screening and Diagnosis
Prostate Cancer Screening, Diagnosis and Prognosis
Screening Controversies
Psa Tests
What Is Psa?
New Types of Psa Tests
Percent-Free Psa
Psa Velocity (Psav)
Psa Density/Psad
Age-Specific Psa Ranges
Risk Stratification
Pca3
Phi
4kscore Test
Confirmmdx
Isopsa Test
Promark
Progensa Pca3
Digital Rectal Exam
Prostate Biopsy
Grade (Gleason Score) of Prostate Cancer
Prostatic Intraepithelial Neoplasia
Atypical Small Acinar Proliferation
Proliferative Inflammatory Atrophy
Prostate Ultrasound
Transrectal Ultrasound
Imaging Technologies for Prostate Cancer
Bone Scan
Computerized Tomography
Magnetic Resonance Imaging
Endorectal Mri Technology
Mri-Trus Fusion
Magnetic Resonance Spectroscopic Imaging
Mri and Mrsi Combination
Proton Radiation therapy
High-Intensity Focused Ultrasound
Pet Scanning
Prostascint Scanning
Lymph Node Biopsy
Laparoscopic Biopsy
Fine Needle Aspiration
Conclusion

Chapter 6 Prostate Cancer: therapeutic Interventions
Treatment Plan
Treatment Options
Watchful Waiting Or Active Surveillance
Treatment Strategies for Prostate Cancer By Stage
Surgery
Robot-Assisted Surgery
Incision In Abdomen
Incision Between the Anus and Scrotum
Laparoscopic Prostatectomy
Cryoablation
Radical Prostatectomy
Secondary therapy
Counseling About Postoperative Erectile Dysfunction
Radiotherapy
Interstitial Brachytherapy for Low-Risk Cancers
External Beam Radiotherapy
Combined Radiation therapy
Cryotherapy
High-Intensity Focused Ultrasound
Focal Ablation
Hormone therapy
androgen Deprivation, An Adjuvant therapy
Post-Treatment Monitoring
Chemoprevention and Chemotherapy
Immunotherapy/therapeutic Vaccines
Vascular-Targeted Photodymanic therapy
Prostvac (Rilimogene Galvacirepvac)
Oncolytic Virus therapy
Prostatak
Hsv-Tk Plus Valacyclovir
Immune Checkpoint Inhibitors
Adoptive Cell therapy
Adjuvant Immunotherapies
Monoclonal Antibodies
Cytokines
Nutritional therapy
Erectile Dysfunction
Emerging therapies
Combination therapy
Drugs for Hormone-Resistance Prostate Cancer
Inhibitors of Kinase Signaling Pathways
Proteasome Inhibitors
Angiogenesis Inhibitors
Conclusion

Chapter 7 Prostate Cancer therapeutics In the Global Market
What Is Cancer?
Drugs Approved for Prostate Cancer
Lupron (Leuprolide Acetate)
Taxotere (Docetaxel)
Jevtana (Cabazitaxel)
Zytiga (Abiraterone Acetate)
Provenge (Sipuleucel-T)
Xgeva (Denosumab)
Avodart (Dutasteride)
Drug Descriptions
Casodex (Bicalutamide)
Clinical Pharmacology
Clinical Studies
Zoladex (Goserelin Acetate)
Clinical Pharmacology
Clinical Studies
Post-Marketing Studies
Eligard (Leuprolide)
Clinical Pharmacology
Clinical Studies
Post-Marketing Studies
Nilandron (Nilutamide)
Clinical Pharmacology
Clinical Studies
Post-Marketing Studies
Flutamide
Clinical Pharmacology
Clinical Studies
Post-Marketing Studies
Triptorelin (Trelstar)
Clinical Pharmacology
Clinical Trials
Post-Marketing Studies
Estramustine (Emcyt)
Clinical Pharmacology
Firmagon (Degarelix Acetate)
Clinical Pharmacology
Clinical Studies
Taxotere (Docetaxel)
Clinical Pharmacology
Clinical Studies
Post-Marketing Studies
Jevtana (Cabazitaxel)
Clinical Pharmacology
Clinical Studies
Mitoxantrone (Novantrone)
Vinorelbine (Navelbine)
Zytiga (Abiraterone Acetate)
Clinical Pharmacology
Clinical Studies
Provenge (Sipuleucel-T)
Clinical Pharmacology
Clinical Studies
Xtandi (Enzalutamide)
Pharmacokinetics
Clinical Studies
Xofigo (Alpharadin)
Other therapeutic Agents
Cabozantinib (Xl184)
Ipilimumab (Yervoy)
Orteronel (Tak-700)
Apalutamide (Inn/Arn-509)
Galeterone (Tok-001 Or Vn/124-1)
Masitinib
Bay-1841788 (Odm-201)
Custirsen (Ogx-011)

Chapter 8 Global Burden of Cancer

Chapter 9 Prostate Cancer and Diagnostic Market
Screening Tests
Psa Testing: Yes Or No Controversy
Prostate Cancer Market Size
Prostate Cancer Screening Market
Diagnostic Tests and Nice
Biopsy
Diagnosis and Further Treatment
Psa Test and Status
Moving forward and Psa Test
Psa Test and Costs
Dre Market
Market for Prostate Biopsy
Psa and Dre Manufacturers and Market
Special Types of Psa Tests
Percent-Free Psa
Complexed Psa
Tests That Combine Different Types of Psa
Psa Velocity
Psa Density
Age-Specific Psa Ranges
Early Detection Tests and Market Opportunity
Myriad Genetics
Prostate Health Index
Mdxhealth
Genomedx Biosciences
Opko Health
Genomic Health
Exosome Diagnostics
Hologic/Gen-Probe
Metamark Genetics
Prostate Cancer Diagnostic Imaging Market
Imaging Market Outlook

Chapter 10 Prostate Cancer Treatment Market
Treatment Plan for Prostate Cancer
Treatment Costs Associated With Prostate Cancer
Prostate Cancer therapies: Three Leading Prostate Cancer therapies
Prostate Cancer Surgery and Radiotherapy Market
Prostate Cancer Surgical Device Market
Radiotherapy Market
Brachytherapy Market
Permanent (Ldr) Brachytherapy
Temporary (Hdr) Brachytherapy
Ultrasound Market
Prostatectomy Market
Urological Market
U.S. Market for Brachytherapy Devices
Hifu In the United States
Robotic Prostatectomy Market
Prostate Cancer Device Market In Asia and Latin America

Chapter 11 Prostate Cancer Drugs Market
Global Oncology therapeutics Market
New Approaches To Treat Prostate Cancer
Cytotoxic therapies Market
Prostate Cancer Incidence and Impact On Market
Prostate Cancer Market Size
Cost of Prostate Cancer therapy, Care and Management
Current Prostate Cancer therapeutics
Generic Prostate Cancer Drugs
Newer therapies On the Market
Recent Drug Approvals and Market
Prostate Cancer: therapeutic Drugs Landscape
Market for Chemotherapy
Market for Chemotherapy Drugs for Prostate Cancer
Taxotere/Docetaxel
Cabazitaxel/Jevtana
Mitoxantrone (Novantrone)
Vinorelbine (Navelbine)
Estramustine (Emcyt)
Market for Hormone therapy
Hormone therapy Drugs
Casodex
Zytiga (Abiraterone)
Xtandi Or Enzalutamide
Flutamide
Nilutamide
Triptorelin
Leuprolide Acetate
Eligard
Zoladex
Degarelix Acetate
Arn-509
Market for Immunotherapy
Provenge
Prostate Cancer Care Market
Conclusion

Chapter 12 Emerging Prostate Cancer Drugs

Chapter 13 Prostate Cancer Patents
Prostate Cancer Drug Patents Expiry
Conclusion

Chapter 14 Selected Company Profiles
Abbott Laboratories
Active Biotech Ab
Algeta
Amgen
Astellas Pharma Us
Astrazeneca
Atrix Laboratories
Bavarian Nordic A/S
Bayer Healthcare Pharmaceuticals
Bristol-Myers Squibb
C.R. Bard
Cz Biomed Corp.
Dendreon Corp.
Diagnocure
Exelixis
Exosome Diagnostics
Ge Healthcare
Genomic Health
Glaxosmithkline
Hologic
Intuitive Surgical
Johnson & Johnson
Medivation
Metamark
Millennium Pharmaceuticals
Myriad Genetics
Northwest Biotherapeutics
Oncogenex
Opko Health
Pfizer
Sanofi
Siemens Ag
Spectrum Pharmaceuticals
Varian Medical Systems

Chapter 15 References and End Notes
End Notes
Global Prostate Cancer Statistics
Prostate Cancer Mortality
Prostate Cancer Burden Globally
Prostate Cancer In the United States
Prostate Cancer Mortality Rates In the U.S.
Prostate Cancer and African-American Men
Survival Rates By Stage
Prostate Cancer and Canada
Prostate Cancer and Europe
Prostate Cancer and the United Kingdom
Prostate Cancer In Asia
Other Nations
Jamaica
Australia
Conclusion
Emerging Products
Cabozantinib
Xgeva
Custirsen
Tasquinimod
Sprycel
Tak-700
Prostvac
Alpharadin
Dcvax-Prostate
Not Approved Drugs
Avodart
Conclusion
References

List of Tables

Summary
Table 1 : Summary Table: Global Prostate Cancer Market, Through 2021
Table 2 : U.S. Preventive Services Task Force Recommendations, 2008
Table 3 : Growth Factors Implicated In Prostate Cancer
Table 4 : Proposed Prostate Cancer Susceptibility Loci
Table 5 : Important Genes In The Development of Prostate Cancer
Table 6 : Mutated Genes And Abnormal Protein Expression
Table 7 : Why Psa Testing?
Table 8 : Signs And Symptoms
Table 9 : Guideline Statements
Table 10 : Prostate Cancer: Major Points
Table 11 : Acs Recommendations For The Early Detection of Cancer In Average-Risk, Asymptomatic Individuals
Table 12 : Prostate Cancer Screening
Table 13 : Limitations of Psa Testing
Table 14 : Psa Test: Why And When?
Table 15 : Age-Specific Reference Ranges For Serum Psa
Table 16 : Other Causes of Changes In Psa Level
Table 17 : Improvements To The Psa Test
Table 18 : Prostate Cancer Diagnosis And Treatment Strategy
Table 19 : Prostate Cancer Tests
Table 20 : Prostate Cancer: Local And Metastatic Symptoms
Table 21 : Diagnostic Methods
Table 22 : Treatment Options For Prostate Cancer
Table 23 : Factors For Prostate Cancer Treatment Planning
Table 24 : Guide To Prostate Cancer Diagnosis And Management
Table 25 : Stage I Prostate Cancer
Table 26 : Stage Ii Prostate Cancer
Table 27 : Stage Iii Prostate Cancer
Table 28 : Stage Iv Prostate Cancer
Table 29 : Types of Surgeries
Table 30 : Advantages And Disadvantages of Radical Prostatectomy
Table 31 : Advantages And Disadvantages of Interstitial Brachytherapy
Table 32 : Advantages And Disadvantages of External Beam Radiotherapy
Table 33 : Advantages And Disadvantages of Cryotherapy
Table 34 : Advantages And Disadvantages of Ultrasound
Table 35 : Hormone Therapy
Table 36 : Common Cancers: Global Cancer Cases, 2012
Table 37 : Therapeutics For Prostate Cancer Treatment
Table 38 : Approved Fda Prostate Cancer Drugs
Table 39 : Common Drugs For Treatment of Prostate Cancer
Table 40 : Xtandi
Table 41 : Xofigo/Alpharadin
Table 42 : Cabozantinib
Table 43 : Therapeutic Agents For Prostate Cancer Under Clinical Development
Table 44 : Global Cancer Incidence Estimates, 2013
Table 45 : Cancer In 2013
Table 46 : World Cancer Statistics For The Most Common Cancers, 2012
Table 47 : Incidence And Deaths For Prostate Cancer, 2013
Table 48 : Prostate Cancer Incidence And Mortality Global, 2012
Table 49 : Highest Incidence of Prostate Cancer, By Country, 2012
Table 50 : Global Estimated Prostate Cancer Deaths: Age-Standardized Mortality Rates Per 100,000 Men, 2012
Table 51 : Global Estimated New Cases of Prostate Cancer, 2008-2030
Table 52 : Prostate Cancer Statistics, 2016
Table 53 : Prostate Cancer Cases And Deaths In The U.S., 2008-2016
Table 54 : Prostate Cancer Statistics: New Cases And Deaths In The U.S., By Race, 2007-2012
Table 55 : Prostate Cancer Stage And Survival Rate
Table 56 : Estimated Prostate Cancer New Cases In The U.S., 2012-2030
Table 57 : Incidence Rates By Race In The U.S., 2005-2009
Table 58 : Estimated Prostate Cancer New Cases In The U.S., 2020-2030
Table 59 : Mortality Rates By Race In The U.S., 2005-2009
Table 60 : Distribution And Five-Year Relative Survival By Stage At Diagnosis For Males of All Races, 2002-2008
Table 61 : Relative Survival Rate For Prostate Cancer Patients
Table 62 : Five-Year Relative Survival By Stage At The Time of Diagnosis
Table 63 : Estimated Prostate Cancer In Canada, 2015
Table 64 : Estimated Prostate Cancer Mortality In Eu27 Countries: Age-Standardized Mortality Rates Per 100,000 Men, 2012
Table 65 : Prostate Cancer Deaths In The U.K.: Rate Per 100,000 People, 2014
Table 66 : Estimated Prostate Cancer Diagnosed In 2016
Table 67 : Types of Diagnostic Tests
Table 68 : Global Psa Test Sales And Forecast, Through 2021
Table 69 : U.S. Psa Test Sales And Forecast, Through 2021
Table 70 : European Psa Test Sales And Forecast, Through 2021
Table 71 : Emerging Markets Psa Test Sales And Forecast, Through 2021
Table 72 : Canadian Psa Test Sales And Forecast, Through 2021
Table 73 : Global Digital Rectal Examination Sales And Forecast, Through 2021
Table 74 : U.S. Digital Rectal Examination Sales And Forecast, Through 2021
Table 75 : Row Digital Rectal Examination Sales And Forecast (Excluding The U.S.), Through 2021
Table 76 : Global Estimated Cost And Forecast of Prostate Biopsies, Through 2021
Table 77 : U.S. Estimated Cost And Forecast of Prostate Biopsies, Through 2021
Table 78 : Row Estimated Cost And Forecast of Prostate Biopsies (Excluding The U.S.), Through 2021
Table 79 : Global Estimated Cost And Forecast For Prostate Biopsies, By Region, Through 2021
Table 80 : Global Prostate Cancer Screening Sales And Forecast, Through 2021
Table 81 : Manufacturers/Suppliers of Prostate Cancer Diagnostics Market, 2016
Table 82 : Newer Tests And Characteristics
Table 83 : List of Available Prostate Nomograms
Table 84 : Global Market For Prostate Cancer Imaging Technologies: Sales And Forecast, Through 2021
Table 85 : Prostate Cancer Therapeutic Options When Local Therapy Fails
Table 86 : Cost of The Three Leading Prostate Cancer Therapies, 2012
Table 87 : Key Players of Surgical Device And Radiotherapy Companies
Table 88 : Global Prostate Cancer Surgery And Radiotherapy Market Sales And Forecast, Through 2021
Table 89 : Global Market For External Beam Radiation Therapy Sales And Forecast, Through 2021
Table 90 : Global Brachytherapy Market Sales And Forecast, Through 2021
Table 91 : Global Estimated Incidence of Prostate Cancer, 2008-2030
Table 92 : Global Estimated Cases of Prostate Surgeries Performed Per Year, 2011-2021
Table 93 : Global Market For Prostate Surgeries Sales And Forecast, Through 2021
Table 94 : Global Cases of Estimated Robotic Prostatectomies Performed Per Year, 2011-2021
Table 95 : Global Market For Robotic Prostatectomy Sales And Forecast, Through 2021
Table 96 : Global Market For Estimated Open Prostatectomy Surgeries Per Year, 2011-2021
Table 97 : Global Market For Open Prostatectomy Sales And Forecast, Through 2021
Table 98 : U.S. Urological Device Market Sales And Forecast, Through 2016
Table 99 : U.S. Brachytherapy Market Sales And Forecast, Through 2021
Table 100 : Prostate Cancer Incidence In The U.S., 2008-2016
Table 101 : U.S. Total Estimated Prostatectomy Cases, 2011-2021
Table 102 : U.S. Robotic Prostatectomy Market Sales And Forecast, Through 2021
Table 103 : U.S. Prostatectomy Surgeries Sales And Forecast, Through 2021
Table 104 : U.S. Open Prostatectomy Market Sales And Forecast, Through 2021
Table 105 : Global Cancer Therapeutic Market, Through 2021
Table 106 : oncology Pipeline, 2016
Table 107 : Global Cytotherapeutics Market, 2010 And 2016
Table 108 : Cytotoxic Therapies Market Indications
Table 109 : Expiry of Patents on Major Cytotoxic Drugs
Table 110 : U.S. Cytotherapeutics Market, Through 2016
Table 111 : European Cytotherapeutics Market, Through 2016
Table 112 : Japanese Cytotherapeutics Market, Through 2016
Table 113 : Major Cytotoxic Brands Sales, 2016
Table 114 : Drug Products And Treatment Market For Prostate Cancer, Through 2021
Table 115 : Current Prostate Cancer Therapies And Costs
Table 116 : Prostate Cancer Drug Market, Through 2021
Table 117 : Prostate Cancer Drug Products, By Treatment Category, Through 2021
Table 118 : U.S. Prostate Cancer Market: Patients And Treatment Strategies
Table 119 : New Drugs And Sales Forecast, 2015 And 2021
Table 120 : Global Sales And Forecast: Key Prostate Cancer Drugs, 2010-2016
Table 121 : Global Prostate Cancer Chemotherapy Drugs
Table 122 : Global Chemotherapy Market For Prostate Cancer Sales And Forecast, Through 2021
Table 123 : Key Chemotherapeutic Drugs For Prostate Cancer Sales And Forecast, 2010-2016
Table 124 : Global Prostate Cancer Hormonal Therapy Drugs
Table 125 : Hormone Therapy For Prostate Cancer Sales And Forecast, Through 2021
Table 126 : Generics Sales And Forecast, Through 2021
Table 127 : Casodex Sales And Forecast, Through 2021
Table 128 : Zytiga Sales Estimates, 2012 And 2015
Table 129 : Global Sales And Forecast For Zytiga, Through 2021
Table 130 : Global Market Sales And Forecast For Xtandi, Through 2021
Table 131 : Global Market For Flutamide, 2009-2010
Table 132 : Global Market For Triptorelin, 2009-2010
Table 133 : Global Market For Lupron, Through 2021
Table 134 : Global Market For Zoladex Sales And Forecast, Through 2021
Table 135 : Global Prostate Cancer Immunotherapy Drug Sales And Forecast, Through 2021
Table 136 : Provenge Annual Sales And Forecast, 2010-2016
Table 137 : Global Market For Prostate Cancer Care, By Region, Through 2021
Table 138 : European Prostate Cancer Care Market, Through 2021
Table 139 : U.S. Prostate Cancer Care Market, Through 2021
Table 140 : Canadian Prostate Cancer Care Market, Through 2021
Table 141 : Global Prostate Cancer Market Sales And Forecast, Through 2021
Table 142 : Emerging Products For Prostate Cancer
Table 143 : Prostate Cancer Patent Trends, 2002-2011
Table 144 : Patents By Treatment Category, 2002-2011
Table 145 : Expiry of Patents on Major Brands
Table 146 : List of Key Dendreon Patents And Patent Applications

List of Figures

Figure 1 : Summary Figure: Global Prostate Cancer Market, 2012-2021
Figure 2 : Chemical Structure of Casodex
Figure 3 : Chemical Structure of Zoladex
Figure 4 : Chemical Structure of Eligard
Figure 5 : Chemical Structure of Nilandron
Figure 6 : Chemical Structure of Flutamide
Figure 7 : Chemical Structure of Trelstar
Figure 8 : Chemical Structure of Estramustine
Figure 9 : Chemical Structure of Firmagon
Figure 10 : Chemical Structure of Docetaxel
Figure 11 : Chemical Structure of Jevtana
Figure 12 : Chemical Structure of Zytiga
Figure 13 : Chemical Structure of Xtandi
Figure 14 : Global Cancer Incidence Estimates, 2013
Figure 15 : Prostate Cancer Incidence And Mortality Global, 2012
Figure 16 : Global Estimated Prostate Cancer Deaths: Age-Standardized Mortality Rates Per 100,000 Men, 2012
Figure 17 : Global Estimated New Cases of Prostate Cancer, 2008-2030
Figure 18 : Prostate Cancer Cases And Deaths In The U.S., 2008-2016
Figure 19 : Estimated Prostate Cancer New Cases In The U.S., 2012-2030
Figure 20 : Estimated Prostate Cancer New Cases In The U.S., 2020-2030
Figure 21 : Estimated Prostate Cancer Mortality In Eu27 Countries: Age-Standardized Mortality Rates Per 100,000 Men, 2012
Figure 22 : Prostate Cancer Deaths In The U.K.: Rate Per 100,000 People, 2014
Figure 23 : Global Psa Test Sales And Forecast, 2010-2021
Figure 24 : U.S. Psa Test Sales And Forecast, 2011-2021
Figure 25 : European Psa Test Sales And Forecast, 2011-2021
Figure 26 : Canadian Psa Test Sales And Forecast, 2011-2021
Figure 27 : Global Digital Rectal Examination Sales And Forecast, 2012-2021
Figure 28 : U.S. Digital Rectal Examination Sales And Forecast, 2016 And 2021
Figure 29 : Row Digital Rectal Examination Sales And Forecast (Excluding The U.S.), 2012-2021
Figure 30 : Global Estimated Cost And Forecast of Prostate Biopsies, 2012-2021
Figure 31 : U.S. Estimated Cost And Forecast of Prostate Biopsies, 2012-2021
Figure 32 : Emerging Markets Psa Test Sales And Forecast, 2010-2021
Figure 33 : Row Estimated Cost And Forecast of Prostate Biopsies (Excluding The U.S.), 2012-2021
Figure 34 : Global Estimated Cost And Forecast For Prostate Biopsies, By Region, 2012-2021
Figure 35 : Global Prostate Cancer Screening Sales And Forecast, 2012-2021
Figure 36 : Global Market For Prostate Cancer Imaging Technologies: Sales And Forecast, 2012-2021
Figure 37 : Global Prostate Cancer Surgery And Radiotherapy Market Sales And Forecast, 2012-2021
Figure 38 : Global Market For External Beam Radiation Therapy Sales And Forecast, 2012-2021
Figure 39 : Global Brachytherapy Market Sales And Forecast, 2012-2021
Figure 40 : Global Estimated Incidence of Prostate Cancer, 2008-2030
Figure 41 : Global Estimated Cases of Prostate Surgeries Performed Per Year, 2011-2021
Figure 42 : Global Market For Prostate Surgeries Sales And Forecast, 2012-2021
Figure 43 : Global Cases of Estimated Robotic Prostatectomies Performed Per Year, 2011-2021
Figure 44 : Global Market For Robotic Prostatectomy Sales And Forecast, 2012-2021
Figure 45 : Global Market For Estimated Open Prostatectomy Surgeries Per Year, 2011-2021
Figure 46 : Global Market For Open Prostatectomy Sales And Forecast, 2012-2021
Figure 47 : U.S. Brachytherapy Market Sales And Forecast, 2012-2021
Figure 48 : Prostate Cancer Incidence In The U.S., 2008-2016
Figure 49 : U.S. Robotic Prostatectomy Market Sales And Forecast, 2011-2021
Figure 50 : U.S. Prostatectomy Surgeries Sales And Forecast, 2012-2021
Figure 51 : U.S. Open Prostatectomy Market Sales And Forecast, 2012-2021
Figure 52 : Global Cancer Therapeutic Market, 2016 And 2021
Figure 53 : U.S. Cytotherapeutics Market, 2010-2016
Figure 54 : European Cytotherapeutics Market, 2010-2016
Figure 55 : Japanese Cytotherapeutics Market, 2010-2016
Figure 56 : Drug Products And Treatment Market For Prostate Cancer, 2012-2021
Figure 57 : Prostate Cancer Drug Market, 2012-2021
Figure 58 : Prostate Cancer Drug Products, By Treatment Category, 2012-2021
Figure 59 : Global Chemotherapy Market For Prostate Cancer Sales And Forecast, 2010-2021
Figure 60 : Hormone Therapy For Prostate Cancer Sales And Forecast, Through 2021
Figure 61 : Casodex Sales And Forecast, 2011-2021
Figure 62 : Zytiga Sales Estimates, 2012 And 2015
Figure 63 : Global Sales And Forecast For Zytiga, 2011-2021
Figure 64 : Global Market For Zoladex Sales And Forecast, 2009-2021
Figure 65 : Global Prostate Cancer Immunotherapy Drug Sales And Forecast, 2010-2021
Figure 66 : Provenge Annual Sales And Forecast, 2010-2016
Figure 67 : Global Market For Prostate Cancer Care, By Region, 2012-2021
Figure 68 : European Prostate Cancer Care Market, 2012-2021
Figure 69 : U.S. Prostate Cancer Care Market, 2012-2021
Figure 70 : Canadian Prostate Cancer Care Market, 2012-2021
Figure 71 : Global Prostate Cancer Market Sales And Forecast, Through 2021

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs